- Home
- TNGX vs VACH Comparison
TNGX vs VACH Comparison
Compare TNGX & VACH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TNGX
- VACH
- Stock Information
- Founded
- TNGX 2014
- VACH 2023
- Country
- TNGX United States
- VACH United States
- Employees
- TNGX N/A
- VACH N/A
- Industry
- TNGX Biotechnology: Pharmaceutical Preparations
- VACH
- Sector
- TNGX Health Care
- VACH
- Exchange
- TNGX Nasdaq
- VACH NYSE
- Market Cap
- TNGX 351.2M
- VACH 329.2M
- IPO Year
- TNGX N/A
- VACH 2024
- Fundamental
- Price
- TNGX $6.01
- VACH $10.41
- Analyst Decision
- TNGX Strong Buy
- VACH
- Analyst Count
- TNGX 6
- VACH 0
- Target Price
- TNGX $12.20
- VACH N/A
- AVG Volume (30 Days)
- TNGX 2.7M
- VACH 76.4K
- Earning Date
- TNGX 08-06-2025
- VACH 01-01-0001
- Dividend Yield
- TNGX N/A
- VACH N/A
- EPS Growth
- TNGX N/A
- VACH N/A
- EPS
- TNGX N/A
- VACH 0.30
- Revenue
- TNGX $40,990,000.00
- VACH N/A
- Revenue This Year
- TNGX N/A
- VACH N/A
- Revenue Next Year
- TNGX N/A
- VACH N/A
- P/E Ratio
- TNGX N/A
- VACH $35.21
- Revenue Growth
- TNGX 10.09
- VACH N/A
- 52 Week Low
- TNGX $1.03
- VACH $9.95
- 52 Week High
- TNGX $12.02
- VACH $11.20
- Technical
- Relative Strength Index (RSI)
- TNGX 76.36
- VACH N/A
- Support Level
- TNGX $5.34
- VACH N/A
- Resistance Level
- TNGX $6.40
- VACH N/A
- Average True Range (ATR)
- TNGX 0.50
- VACH 0.00
- MACD
- TNGX -0.02
- VACH 0.00
- Stochastic Oscillator
- TNGX 84.08
- VACH 0.00
About TNGX Tango Therapeutics Inc.
Tango Therapeutics Inc is a biotechnology company. It is dedicated to discovering novel drug targets and delivering the next generation of precision medicine for the treatment of cancer. It is engaged in the business of discovering and developing precision oncology therapies. It is currently developing two MTA-cooperative PRMT5 inhibitors; TNG462 for non-CNS cancers, including pancreatic and lung cancer, and TNG456, a next-generation, brain-penetrant PRMT5 inhibitor, for CNS cancers, including GBM. Its pipeline products are PRMT5 and CoREST.
About VACH VOYAGER ACQUISITION CORP.
Voyager Acquisition Corp is a blank check company.